Open mitochondrial research · Plain-language explainer

Published on Zenodo · October 13, 2026

POLG Liver Vulnerability Requires Genotype, mtDNA Maintenance and Regeneration-Stress Context

Friedl, Andrew

Abstract

**Background:** POLG encodes the catalytic subunit of mitochondrial DNA polymerase gamma. POLG-related liver discussions often compress genotype, valproate exposure, acute liver failure severity, primary liver mitochondrial DNA content, and hepatocyte recovery into one explanation.

**Objective:** This working paper asks whether public primary sources distinguish a DNA polymerase gamma mtDNA-maintenance/regeneration-stress bottleneck from ordinary acute-liver-failure or valproate-toxicity explanations in POLG-related hepatic vulnerability.

**Methods:** Six complete public primary texts were source-coded: four central POLG/ALF records and two current-search boundary records. Endpoint classes were genotype association, human-cell proliferation, mouse CCl4 recovery, VPA boundary evidence, primary liver mtDNA content, patient-tissue specificity, and pediatric ALF incidence. The analysis was a non-pooling public source comparison with decision-changing, robustness, and exploratory sensitivity checks; it did not estimate clinical efficacy, patient-level risk, VPA safety, transplant outcomes, or a pooled biological effect.

**Results:** Stewart 2010 supplied the human VPA/POLG association and proliferation signal; Silva-Pinheiro 2021 supplied Polg A449T/A449T CCl4 recovery impairment and a VPA-negative mouse boundary; Helbling 2013 supplied the general ALF mtDNA-maintenance comparator; Schaller 2011 and Muller-Hocker 2011 supported primary-tissue liver depletion in POLG contexts; and McKiernan 2016 placed POLG inside a wider pediatric mitochondrial liver-disease differential. Removing Stewart or Silva-Pinheiro changed the research decision, while retaining Helbling prevented over-specific POLG assignment.

**Conclusions:** Current complete-text evidence supports a bounded research-design rule rather than a validated causal mechanism. POLG hepatic-vulnerability studies should measure genotype or POLgamma-function class, primary liver mtDNA content, stress exposure, and hepatocyte proliferation or regeneration endpoints together before interpreting liver failure as a POLG-specific regeneration-stress bottleneck rather than broader ALF mtDNA-maintenance vulnerability or ordinary drug/injury context.

Download the manuscript PDF

DOI: 10.5281/zenodo.23342101

The paper at a glance

The question

POLG is a gene needed to maintain mitochondrial DNA. Some reports connect POLG with severe liver injury, but liver failure can also have many other causes.

Main takeaway

The evidence supports a cautious research rule: POLG liver studies should measure the gene context, liver mitochondrial DNA, stress exposure, and regeneration endpoints together.

Important caution

The paper does not prove a treatment, estimate an individual risk, recommend valproate use or avoidance, or make a transplant recommendation.

Why this matters

POLG is a gene needed to maintain mitochondrial DNA. Some reports connect POLG with severe liver injury, but liver failure can also have many other causes.

How the research was done

The paper compared public studies in people, mice, and patient tissues. It looked for genotype evidence, liver mitochondrial DNA evidence, stress exposure, and signs of regeneration or cell proliferation.

What the researchers found

The evidence supports a cautious research rule: POLG liver studies should measure the gene context, liver mitochondrial DNA, stress exposure, and regeneration endpoints together.

What this does not prove

The paper does not prove a treatment, estimate an individual risk, recommend valproate use or avoidance, or make a transplant recommendation.

What researchers should test next

A useful next study would test matched liver or hepatocyte systems across POLG genotypes and stress conditions while measuring mitochondrial DNA and regeneration directly.

Helpful definitions

Key terms in plain English

MitochondriaStructures inside cells that convert fuel into energy the cell can use.

See the evidence

Visual findings

Visual finding 1. Figure 1 analysis-process figure
Visual finding 2. Figure 2 concept-summary figure

For non-specialists

What this could mean for patients and families

This is a research-planning paper, not medical advice. Medication and liver-care decisions should be made with qualified clinicians who know the individual case.

  • Has the person been evaluated for POLG or another mitochondrial DNA-maintenance gene when liver failure and seizures are present?
  • Was liver mitochondrial DNA measured in primary liver tissue, or was the evidence inferred from another tissue?
  • Does the study separate valproate exposure from other causes of acute liver failure?